Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Surgeon Characteristics and Dialysis Vascular Access Outcomes in the United States: A Retrospective Cohort Study.

Shahinian VB, Zhang X, Tilea AM, He K, Schaubel DE, Wu W, Pisoni R, Robinson B, Saran R, Woodside KJ.

Am J Kidney Dis. 2019 Oct 1. pii: S0272-6386(19)30911-4. doi: 10.1053/j.ajkd.2019.08.001. [Epub ahead of print]

PMID:
31585684
2.

Prognostic score matching methods for estimating the average effect of a non-reversible binary time-dependent treatment on the survival function.

He K, Li Y, Rao PS, Sung RS, Schaubel DE.

Lifetime Data Anal. 2019 Oct 1. doi: 10.1007/s10985-019-09485-x. [Epub ahead of print]

PMID:
31576491
3.

Penalized Survival Models for the Analysis of Alternating Recurrent Event Data.

Wang L, He K, Schaubel DE.

Biometrics. 2019 Sep 19. doi: 10.1111/biom.13153. [Epub ahead of print]

PMID:
31535737
4.

Computationally efficient inference for center effects based on restricted mean survival time.

Wang X, Zhong Y, Mukhopadhyay P, Schaubel DE.

Stat Med. 2019 Nov 20;38(26):5133-5145. doi: 10.1002/sim.8356. Epub 2019 Sep 9.

PMID:
31502288
5.

The temporal and long-term impact of donor body mass index on recipient outcomes after kidney transplantation - a retrospective study.

Naik AS, Zhong Y, Parasuraman R, Doshi M, Norman S, Lu Y, Shaban E, Shahinian V, Schaubel DE.

Transpl Int. 2019 Sep 3. doi: 10.1111/tri.13505. [Epub ahead of print]

PMID:
31478267
6.

Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease: An Analysis of the US Renal Data System.

Modi ZJ, Lu Y, Ji N, Kapke A, Selewski DT, Dietrich X, Abbott K, Nallamothu BK, Schaubel DE, Saran R, Gipson DS.

JAMA Cardiol. 2019 Apr 1;4(4):353-362. doi: 10.1001/jamacardio.2019.0375.

PMID:
30892557
7.

Response by Siontis et al to Letter Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States".

Siontis KC, Zhang X, Schaubel DE, Yao X, Noseworthy PA, Shah ND, Saran R, Nallamothu BK.

Circulation. 2019 Mar 19;139(12):1563-1564. doi: 10.1161/CIRCULATIONAHA.118.039290. No abstract available.

PMID:
30883218
8.

US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Saran R, Robinson B, Abbott KC, Agodoa LYC, Bragg-Gresham J, Balkrishnan R, Bhave N, Dietrich X, Ding Z, Eggers PW, Gaipov A, Gillen D, Gipson D, Gu H, Guro P, Haggerty D, Han Y, He K, Herman W, Heung M, Hirth RA, Hsiung JT, Hutton D, Inoue A, Jacobsen SJ, Jin Y, Kalantar-Zadeh K, Kapke A, Kleine CE, Kovesdy CP, Krueter W, Kurtz V, Li Y, Liu S, Marroquin MV, McCullough K, Molnar MZ, Modi Z, Montez-Rath M, Moradi H, Morgenstern H, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O'Hare AM, Obi Y, Park C, Pearson J, Pisoni R, Potukuchi PK, Repeck K, Rhee CM, Schaubel DE, Schrager J, Selewski DT, Shamraj R, Shaw SF, Shi JM, Shieu M, Sim JJ, Soohoo M, Steffick D, Streja E, Sumida K, Kurella Tamura M, Tilea A, Turf M, Wang D, Weng W, Woodside KJ, Wyncott A, Xiang J, Xin X, Yin M, You AS, Zhang X, Zhou H, Shahinian V.

Am J Kidney Dis. 2019 Mar;73(3S1):A7-A8. doi: 10.1053/j.ajkd.2019.01.001. Epub 2019 Feb 21. No abstract available.

9.

Evaluating center-specific long-term outcomes through differences in mean survival time: Analysis of national kidney transplant data.

He K, Ashby VB, Schaubel DE.

Stat Med. 2019 May 20;38(11):1957-1967. doi: 10.1002/sim.8076. Epub 2019 Jan 4.

PMID:
30609113
10.

Reevaluation of the Kidney Donor Risk Index.

Zhong Y, Schaubel DE, Kalbfleisch JD, Ashby VB, Rao PS, Sung RS.

Transplantation. 2019 Aug;103(8):1714-1721. doi: 10.1097/TP.0000000000002498.

PMID:
30451742
11.

Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States.

Siontis KC, Zhang X, Eckard A, Bhave N, Schaubel DE, He K, Tilea A, Stack AG, Balkrishnan R, Yao X, Noseworthy PA, Shah ND, Saran R, Nallamothu BK.

Circulation. 2018 Oct 9;138(15):1519-1529. doi: 10.1161/CIRCULATIONAHA.118.035418. Erratum in: Circulation. 2018 Oct 9;138(15):e425.

12.

Semiparametric temporal process regression of survival-out-of-hospital.

Zhan T, Schaubel DE.

Lifetime Data Anal. 2019 Apr;25(2):322-340. doi: 10.1007/s10985-018-9433-8. Epub 2018 May 23.

PMID:
29796979
13.

Multicenter Study of Staging and Therapeutic Predictors of Hepatocellular Carcinoma Recurrence Following Transplantation.

Welling TH, Eddinger K, Carrier K, Zhu D, Kleaveland T, Moore DE, Schaubel DE, Abt PL.

Liver Transpl. 2018 Sep;24(9):1233-1242. doi: 10.1002/lt.25194.

14.

Statistical Methods in Organ Failure and Transplantation.

Schaubel DE.

Stat Biosci. 2017 Dec;9(2):317-319. doi: 10.1007/s12561-017-9207-y. Epub 2017 Nov 27. No abstract available.

15.

Estimating the effect of a rare time-dependent treatment on the recurrent event rate.

Smith AR, Zhu D, Goodrich NP, Merion RM, Schaubel DE.

Stat Med. 2018 May 30;37(12):1986-1996. doi: 10.1002/sim.7626. Epub 2018 Feb 26.

16.

US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Saran R, Robinson B, Abbott KC, Agodoa LYC, Bhave N, Bragg-Gresham J, Balkrishnan R, Dietrich X, Eckard A, Eggers PW, Gaipov A, Gillen D, Gipson D, Hailpern SM, Hall YN, Han Y, He K, Herman W, Heung M, Hirth RA, Hutton D, Jacobsen SJ, Jin Y, Kalantar-Zadeh K, Kapke A, Kovesdy CP, Lavallee D, Leslie J, McCullough K, Modi Z, Molnar MZ, Montez-Rath M, Moradi H, Morgenstern H, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O'Hare AM, Obi Y, Park C, Pearson J, Pisoni R, Potukuchi PK, Rao P, Repeck K, Rhee CM, Schrager J, Schaubel DE, Selewski DT, Shaw SF, Shi JM, Shieu M, Sim JJ, Soohoo M, Steffick D, Streja E, Sumida K, Tamura MK, Tilea A, Tong L, Wang D, Wang M, Woodside KJ, Xin X, Yin M, You AS, Zhou H, Shahinian V.

Am J Kidney Dis. 2018 Mar;71(3 Suppl 1):A7. doi: 10.1053/j.ajkd.2018.01.002. No abstract available. Erratum in: Am J Kidney Dis. 2018 Apr;71(4):501.

17.

Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study.

Woodside KJ, Bell S, Mukhopadhyay P, Repeck KJ, Robinson IT, Eckard AR, Dasmunshi S, Plattner BW, Pearson J, Schaubel DE, Pisoni RL, Saran R.

Am J Kidney Dis. 2018 Jun;71(6):793-801. doi: 10.1053/j.ajkd.2017.11.020. Epub 2018 Feb 9. Erratum in: Am J Kidney Dis. 2018 Aug;72(2):314.

18.

Tobit regression for modeling mean survival time using data subject to multiple sources of censoring.

Gong Q, Schaubel DE.

Pharm Stat. 2018 Mar;17(2):117-125. doi: 10.1002/pst.1844. Epub 2018 Jan 22.

19.

Methods for Contrasting Gap Time Hazard Functions: Application to Repeat Liver Transplantation.

Shu X, Schaubel DE.

Stat Biosci. 2017 Dec;9(2):470-488. doi: 10.1007/s12561-016-9168-6. Epub 2016 Sep 26.

20.

Special issue dedicated to Jack Kalbfleisch.

Schaubel DE, Nan B.

Lifetime Data Anal. 2018 Jan;24(1):1-2. doi: 10.1007/s10985-017-9416-1. No abstract available.

21.

Impact of screening for metabolic syndrome on the evaluation of obese living kidney donors.

Marcusa DP, Schaubel DE, Woodside KJ, Sung RS.

Am J Surg. 2018 Jan;215(1):144-150. doi: 10.1016/j.amjsurg.2017.08.019. Epub 2017 Sep 1.

PMID:
28882358
22.

A C-index for recurrent event data: Application to hospitalizations among dialysis patients.

Kim S, Schaubel DE, McCullough KP.

Biometrics. 2018 Jun;74(2):734-743. doi: 10.1111/biom.12761. Epub 2017 Aug 3.

23.

Initiation of Sevelamer and Mortality among Hemodialysis Patients Treated with Calcium-Based Phosphate Binders.

Komaba H, Wang M, Taniguchi M, Yamamoto S, Nomura T, Schaubel DE, Smith AR, Zee J, Karaboyas A, Bieber B, Fukagawa M, Tentori F.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1489-1497. doi: 10.2215/CJN.13091216. Epub 2017 Jul 19.

24.

National assessment of early hospitalization after liver transplantation: Risk factors and association with patient survival.

Sharma P, Goodrich NP, Schaubel DE, Smith AR, Merion RM.

Liver Transpl. 2017 Sep;23(9):1143-1152. doi: 10.1002/lt.24813.

25.

Evaluating center performance in the competing risks setting: Application to outcomes of wait-listed end-stage renal disease patients.

Dharmarajan SH, Schaubel DE, Saran R.

Biometrics. 2018 Mar;74(1):289-299. doi: 10.1111/biom.12739. Epub 2017 Jul 6.

26.

US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Saran R, Robinson B, Abbott KC, Agodoa LY, Albertus P, Ayanian J, Balkrishnan R, Bragg-Gresham J, Cao J, Chen JL, Cope E, Dharmarajan S, Dietrich X, Eckard A, Eggers PW, Gaber C, Gillen D, Gipson D, Gu H, Hailpern SM, Hall YN, Han Y, He K, Hebert H, Helmuth M, Herman W, Heung M, Hutton D, Jacobsen SJ, Ji N, Jin Y, Kalantar-Zadeh K, Kapke A, Katz R, Kovesdy CP, Kurtz V, Lavalee D, Li Y, Lu Y, McCullough K, Molnar MZ, Montez-Rath M, Morgenstern H, Mu Q, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O'Hare AM, Obi Y, Pearson J, Pisoni R, Plattner B, Port FK, Potukuchi P, Rao P, Ratkowiak K, Ravel V, Ray D, Rhee CM, Schaubel DE, Selewski DT, Shaw S, Shi J, Shieu M, Sim JJ, Song P, Soohoo M, Steffick D, Streja E, Tamura MK, Tentori F, Tilea A, Tong L, Turf M, Wang D, Wang M, Woodside K, Wyncott A, Xin X, Zang W, Zepel L, Zhang S, Zho H, Hirth RA, Shahinian V.

Am J Kidney Dis. 2017 Mar;69(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2016.12.004. Review. No abstract available. Erratum in: Am J Kidney Dis. 2017 May;69(5):712.

27.

Modeling restricted mean survival time under general censoring mechanisms.

Wang X, Schaubel DE.

Lifetime Data Anal. 2018 Jan;24(1):176-199. doi: 10.1007/s10985-017-9391-6. Epub 2017 Feb 21.

28.

National Assessment of Hospitalization Rates for Incident End-Stage Renal Disease After Liver Transplantation.

Goodrich NP, Schaubel DE, Smith AR, Merion RM, Sharma P.

Transplantation. 2016 Oct;100(10):2115-21. doi: 10.1097/TP.0000000000001348.

29.

Estimating the average treatment effect on survival based on observational data and using partly conditional modeling.

Gong Q, Schaubel DE.

Biometrics. 2017 Mar;73(1):134-144. doi: 10.1111/biom.12542. Epub 2016 May 18.

30.

US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Saran R, Li Y, Robinson B, Abbott KC, Agodoa LY, Ayanian J, Bragg-Gresham J, Balkrishnan R, Chen JL, Cope E, Eggers PW, Gillen D, Gipson D, Hailpern SM, Hall YN, He K, Herman W, Heung M, Hirth RA, Hutton D, Jacobsen SJ, Kalantar-Zadeh K, Kovesdy CP, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, Nguyen DV, O'Hare AM, Plattner B, Pisoni R, Port FK, Rao P, Rhee CM, Sakhuja A, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, White S, Woodside K, Hirth RA.

Am J Kidney Dis. 2016 Mar;67(3 Suppl 1):Svii, S1-305. doi: 10.1053/j.ajkd.2015.12.014. Review. No abstract available.

31.

Semiparametric Contrasts of Cumulative Pre-Treatment Mortality in the Presence of Dependent Censoring.

Gong Q, Schaubel DE.

Stat Biosci. 2015 Oct 1;7(2):245-261. Epub 2014 Jul 2.

32.

Semiparametric methods to contrast gap time survival functions: Application to repeat kidney transplantation.

Shu X, Schaubel DE.

Biometrics. 2016 Jun;72(2):525-34. doi: 10.1111/biom.12427. Epub 2015 Oct 26.

33.

A Propensity Score Analysis of the Impact of Invasive Intracranial Pressure Monitoring on Outcomes after Severe Traumatic Brain Injury.

Agrawal D, Raghavendran K, Schaubel DE, Mishra MC, Rajajee V.

J Neurotrauma. 2016 May 1;33(9):853-8. doi: 10.1089/neu.2015.4015. Epub 2015 Oct 8.

34.

Time-dependent prognostic score matching for recurrent event analysis to evaluate a treatment assigned during follow-up.

Smith AR, Schaubel DE.

Biometrics. 2015 Dec;71(4):950-9. doi: 10.1111/biom.12361. Epub 2015 Aug 21.

35.

US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R, Bragg-Gresham J, Chen JT, Cope E, Gipson D, He K, Herman W, Heung M, Hirth RA, Jacobsen SS, Kalantar-Zadeh K, Kovesdy CP, Leichtman AB, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, O'Hare AM, Pisoni R, Plattner B, Port FK, Rao P, Rhee CM, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, Eggers PW, Agodoa LY, Abbott KC.

Am J Kidney Dis. 2015 Jul;66(1 Suppl 1):Svii, S1-305. doi: 10.1053/j.ajkd.2015.05.001. No abstract available. Erratum in: Am J Kidney Dis. 2015 Sep;66(3):545. Am J Kidney Dis. 2015 Sep;66(3):545.

36.

A Perspective on the Scientific Registry of Transplant Recipients' Migration to Bayesian Methods.

Kalbfleisch JD, Schaubel DE.

Am J Transplant. 2015 Aug;15(8):2271-2. doi: 10.1111/ajt.13354. Epub 2015 Jun 19. No abstract available.

37.
38.

Comparing center-specific cumulative incidence functions.

Fan L, Schaubel DE.

Lifetime Data Anal. 2016 Jan;22(1):17-37. doi: 10.1007/s10985-015-9324-1. Epub 2015 Mar 20.

39.

A Reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation.

Sung RS, Zhang M, Schaubel DE, Shu X, Magee JC.

Transplantation. 2015 Sep;99(9):1900-6. doi: 10.1097/TP.0000000000000663.

40.

Serum sodium and survival benefit of liver transplantation.

Sharma P, Schaubel DE, Goodrich NP, Merion RM.

Liver Transpl. 2015 Mar;21(3):308-13. doi: 10.1002/lt.24063. Epub 2015 Feb 10.

41.
42.

Methods for Estimating Center Effects on Recurrent Events.

Liu D, Kalbfleisch JD, Schaubel DE.

Stat Biosci. 2014 May 1;6(1):19-37.

43.

A weighted cumulative sum (WCUSUM) to monitor medical outcomes with dependent censoring.

Sun RJ, Kalbfleisch JD, Schaubel DE.

Stat Med. 2014 Aug 15;33(18):3114-29. doi: 10.1002/sim.6139. Epub 2014 Mar 13.

44.

Semiparametric methods for center effect measures based on the ratio of survival functions.

He K, Schaubel DE.

Lifetime Data Anal. 2014 Oct;20(4):619-44. doi: 10.1007/s10985-014-9293-9. Epub 2014 Feb 28.

45.

Methods for comparing center-specific survival outcomes using direct standardization.

He K, Schaubel DE.

Stat Med. 2014 May 30;33(12):2048-61. doi: 10.1002/sim.6089. Epub 2014 Jan 17.

46.

Disparities in liver transplantation: the association between donor quality and recipient race/ethnicity and sex.

Mathur AK, Schaubel DE, Zhang H, Guidinger MK, Merion RM.

Transplantation. 2014 Apr 27;97(8):862-9. doi: 10.1097/01.tp.0000438634.44461.67.

47.

Patient-specific prediction of ESRD after liver transplantation.

Sharma P, Goodrich NP, Schaubel DE, Guidinger MK, Merion RM.

J Am Soc Nephrol. 2013 Dec;24(12):2045-52. doi: 10.1681/ASN.2013040436. Epub 2013 Sep 12.

48.

Comparison of methods for estimating the effect of salvage therapy in prostate cancer when treatment is given by indication.

Taylor JM, Shen J, Kennedy EH, Wang L, Schaubel DE.

Stat Med. 2014 Jan 30;33(2):257-74. doi: 10.1002/sim.5890. Epub 2013 Jul 3.

49.

Proportional hazards regression in the presence of missing study eligibility information.

Pan Q, Schaubel DE.

Lifetime Data Anal. 2014 Jul;20(3):424-43. doi: 10.1007/s10985-013-9273-5. Epub 2013 Jun 22.

50.

An estimating function approach to the analysis of recurrent and terminal events.

Kalbfleisch JD, Schaubel DE, Ye Y, Gong Q.

Biometrics. 2013 Jun;69(2):366-74. doi: 10.1111/biom.12025. Epub 2013 May 7.

Supplemental Content

Loading ...
Support Center